Toxoplasma gondii is a specialized intracellular parasitic human-animal parasite that can infect almost all warm-blooded animals, including humans, domestic animals, poultry and wild animals, and can cause severe human-animal toxoplasmosis. The disease mainly causes miscarriage, premature birth, stillbirth, abnormal fetus and even fetal death in pregnant women or pregnant animals. Toxoplasma gondii infection in immunocompromised or immunodeficient individuals is a major cause of death. Porcine toxoplasmosis can cause disease in the whole pig farm, with a mortality rate of more than 60%, causing huge economic losses and seriously affecting the development of the farming industry. In recent years, with the development of genomics technology, the genomic study of Toxoplasma gondii has made important progress, which has important biological and clinical significance.

Ace Therapeutics provides genome-level sequencing and analysis services of Toxoplasma gondii, aiming to contribute to the study of the origin, evolution and functional genomics of Toxoplasma gondii. In-depth studies on its biological properties, evolutionary features and regulatory genes will provide more valuable information on the molecular mechanisms of Toxoplasma gondii-host interactions and the development of anti-Toxoplasma drugs for animals.

Genome Sequencing Service Options for Toxoplasma gondii

We have a technical team with extensive experience in holography and can currently provide sequencing and analysis services for toxoplasma at various genomic levels, as described below. Upon completion of the service, we will deliver a detailed report to you. If you want to know more, you are welcome to consult us.

• Whole genome resequencing service for toxoplasma

We use this technology to perform comprehensive variation detection in toxoplasmas, such as single nucleic first acid polymorphism (SNP), insertional deletion (InDel) and structural variation (SV), to deeply analyze all aspects of genetic variation, and to facilitate the discovery of novel and rare genetic variants.

• Genome de novo sequencing service for toxoplasma

We provide genome denovo sequencing and analysis services for toxoplasmas. The genome of Toxoplasma was sequenced without relying on any known genome sequence information, and then bioinformatics was applied to splice and assemble the sequenced sequences to obtain the genome sequence map of Toxoplasma, and to explore the origin and evolution of the organism by comparative genomic methods. Obtaining a whole genome sequence of Toxoplasma by de novo sequencing is an important way to rapidly understand this species.

• Whole exome sequencing (WES) service for toxoplasma

We offer whole-exome sequencing (WES) and analysis services for toxoplasmas. The target area is more clearly defined, with deeper coverage, higher data accuracy, and more economical, especially for analysis of a large number of samples.

• Simplified genome sequencing service for toxoplasma

We offer simplified genome sequencing and analysis services for toxoplasmas. It is mainly used to develop molecular markers, which in turn can be used for population evolution, GWAS, map construction, BSA localization, etc., and provide the theoretical basis for functional gene mining. You only need to provide samples, we can complete the whole process from extraction, library preparation, sequencing to bioinformatic analysis

• Target sequence capture sequencing service for toxoplasma

We provide target sequence capture sequencing services for toxoplasma. In-depth studies of specific regions with less data volume can yield deeper coverage and higher data accuracy.

Service Details

Sample requirements: each service is with independent sample requirements, please consult our technical engineers or sales staff for details.
Delivery content: experiment report.
Test fee: please get it through online inquiry.

Service Flow

1. Communicate your project requirements with us via online inquiry or by phone.
2. Sign the contract and pay the deposit. Fill out the sample order and send the sample.
3. We officially start the experimental procedure, fully launch the experiment and ensure the effective implementation of the project.
4. The customer pays the balance, we deliver the experimental results and provide after-sales service.

Our Advantages

• Good sequencing quality - Each sequencing platform performs strict quality control to ensure sequencing quality.
• Diversified platforms - Multi-technology platforms (PacBio/Nanopore/DNBSEQ/Hi-C) provide a total solution for genomic level sequencing and analysis of Toxoplasma gondii.
• Rich experience - Our analysts have been in the field for a long time, have deep experience and are proficient in various analyses related to genomic products, and can provide you with professional consulting services.
• High output - We have successfully sequenced and analyzed the genomes of many parasite species and published hundreds of articles in top journals.

• Parasitology discovery and pre-research service
• Parasitology metabolism research service
• Parasitology target and structure function research
• Parasitology effectiveness evaluation service
• Parasitology safety evaluation service
• Parasitology pharmacological research service